Molecules that target beta-amyloid

Cliff I. Stains, Kalyani Mondal, Indraneel Ghosh

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

The devastating effects of Alzheimer's and related amyloidogenic diseases have inspired the synthesis and evaluation of numerous ligands to understand the molecular mechanism of the aggregation of the beta-amyloid peptide. Our review focuses on the current knowledge in this field with respect to molecules that have been demonstrated to interact with either oligomeric or fibrillar forms of the beta-amyloid peptide. We describe natural proteins, peptides, peptidomimetics, and small molecules that have been found to interfere with beta-amyloid aggregation. We also detail recent efforts in selecting molecules that target beta-amyloid isolated from antibody, protein, and peptide libraries. These new molecules will likely aid in deciphering the details of the aggregation pathway for the beta-amyloid peptide and provide reagents that may stabilize relevant oligomeric intermediates which likely have bearing on the pathophysiology of Alzheimer's disease. Moreover, the described anti-amyloid molecular toolbox will also provide an avenue for designing new diagnostic and therapeutic reagents.

Original languageEnglish (US)
Pages (from-to)1674-1692
Number of pages19
JournalChemMedChem
Volume2
Issue number12
DOIs
StatePublished - Dec 10 2007

Fingerprint

Amyloid beta-Peptides
Amyloid
Molecules
Agglomeration
Peptidomimetics
Peptide Library
Bearings (structural)
Alzheimer Disease
Proteins
Ligands
Peptides
Antibodies
Therapeutics

Keywords

  • Alzheimers
  • Amyloid
  • Peptides
  • Proteins
  • Small molecules

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Organic Chemistry
  • Molecular Medicine

Cite this

Molecules that target beta-amyloid. / Stains, Cliff I.; Mondal, Kalyani; Ghosh, Indraneel.

In: ChemMedChem, Vol. 2, No. 12, 10.12.2007, p. 1674-1692.

Research output: Contribution to journalArticle

Stains, CI, Mondal, K & Ghosh, I 2007, 'Molecules that target beta-amyloid', ChemMedChem, vol. 2, no. 12, pp. 1674-1692. https://doi.org/10.1002/cmdc.200700140
Stains, Cliff I. ; Mondal, Kalyani ; Ghosh, Indraneel. / Molecules that target beta-amyloid. In: ChemMedChem. 2007 ; Vol. 2, No. 12. pp. 1674-1692.
@article{2cf3ea2294a94d7b911bf06b8975c61a,
title = "Molecules that target beta-amyloid",
abstract = "The devastating effects of Alzheimer's and related amyloidogenic diseases have inspired the synthesis and evaluation of numerous ligands to understand the molecular mechanism of the aggregation of the beta-amyloid peptide. Our review focuses on the current knowledge in this field with respect to molecules that have been demonstrated to interact with either oligomeric or fibrillar forms of the beta-amyloid peptide. We describe natural proteins, peptides, peptidomimetics, and small molecules that have been found to interfere with beta-amyloid aggregation. We also detail recent efforts in selecting molecules that target beta-amyloid isolated from antibody, protein, and peptide libraries. These new molecules will likely aid in deciphering the details of the aggregation pathway for the beta-amyloid peptide and provide reagents that may stabilize relevant oligomeric intermediates which likely have bearing on the pathophysiology of Alzheimer's disease. Moreover, the described anti-amyloid molecular toolbox will also provide an avenue for designing new diagnostic and therapeutic reagents.",
keywords = "Alzheimers, Amyloid, Peptides, Proteins, Small molecules",
author = "Stains, {Cliff I.} and Kalyani Mondal and Indraneel Ghosh",
year = "2007",
month = "12",
day = "10",
doi = "10.1002/cmdc.200700140",
language = "English (US)",
volume = "2",
pages = "1674--1692",
journal = "ChemMedChem",
issn = "1860-7179",
publisher = "John Wiley and Sons Ltd",
number = "12",

}

TY - JOUR

T1 - Molecules that target beta-amyloid

AU - Stains, Cliff I.

AU - Mondal, Kalyani

AU - Ghosh, Indraneel

PY - 2007/12/10

Y1 - 2007/12/10

N2 - The devastating effects of Alzheimer's and related amyloidogenic diseases have inspired the synthesis and evaluation of numerous ligands to understand the molecular mechanism of the aggregation of the beta-amyloid peptide. Our review focuses on the current knowledge in this field with respect to molecules that have been demonstrated to interact with either oligomeric or fibrillar forms of the beta-amyloid peptide. We describe natural proteins, peptides, peptidomimetics, and small molecules that have been found to interfere with beta-amyloid aggregation. We also detail recent efforts in selecting molecules that target beta-amyloid isolated from antibody, protein, and peptide libraries. These new molecules will likely aid in deciphering the details of the aggregation pathway for the beta-amyloid peptide and provide reagents that may stabilize relevant oligomeric intermediates which likely have bearing on the pathophysiology of Alzheimer's disease. Moreover, the described anti-amyloid molecular toolbox will also provide an avenue for designing new diagnostic and therapeutic reagents.

AB - The devastating effects of Alzheimer's and related amyloidogenic diseases have inspired the synthesis and evaluation of numerous ligands to understand the molecular mechanism of the aggregation of the beta-amyloid peptide. Our review focuses on the current knowledge in this field with respect to molecules that have been demonstrated to interact with either oligomeric or fibrillar forms of the beta-amyloid peptide. We describe natural proteins, peptides, peptidomimetics, and small molecules that have been found to interfere with beta-amyloid aggregation. We also detail recent efforts in selecting molecules that target beta-amyloid isolated from antibody, protein, and peptide libraries. These new molecules will likely aid in deciphering the details of the aggregation pathway for the beta-amyloid peptide and provide reagents that may stabilize relevant oligomeric intermediates which likely have bearing on the pathophysiology of Alzheimer's disease. Moreover, the described anti-amyloid molecular toolbox will also provide an avenue for designing new diagnostic and therapeutic reagents.

KW - Alzheimers

KW - Amyloid

KW - Peptides

KW - Proteins

KW - Small molecules

UR - http://www.scopus.com/inward/record.url?scp=48849104834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48849104834&partnerID=8YFLogxK

U2 - 10.1002/cmdc.200700140

DO - 10.1002/cmdc.200700140

M3 - Article

C2 - 17952881

AN - SCOPUS:48849104834

VL - 2

SP - 1674

EP - 1692

JO - ChemMedChem

JF - ChemMedChem

SN - 1860-7179

IS - 12

ER -